Korean Clinical Practice Guideline of Korean Society for Research on Nicotine and Tobacco (KSRNT) and National Evidence-based Healthcare Collaborating Agency (NECA) on Treatment of Tobacco Use 2024.

ABSTRACT: Tobacco use is a leading cause of preventable death, disease, and disability worldwide. Thus, smoking cessation is a critical public health intervention globally. This clinical practice guideline was developed to provide recommendations on pharmacological and non-pharmacological treatments for smoking cessation, tailored strategies for smoking cessation in special populations, and interventions for users of electronic cigarettes and multiple tobacco products. Thirty key questions and corresponding evidence-based recommendations were derived from systematic reviews, meta-analyses, and de novo development. A multidisciplinary panel of experts participated in the development of this guideline, incorporating evaluation of evidence quality, benefit-risk balance, patient values and preferences,

SUBMITTER: Seo YB 

PROVIDER: S-EPMC12518755 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature